切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - M1 Receptors - Inward Rectifier Potassium (Kir) Channels - P-glycoprotein (P-gp) - RSK

18件产品中的 1-10

页面
每页
清除全部
  1. ACTB-1003
    B4904 ACTB-1003
    Target: VEGFR|FGFR|Tie-2|RSK|p70 S6K
    Summary: FGFR1抑制剂
      ≥18.15 mg/mL
      insoluble in H2O
  2. Telenzepine dihydrochloride
    B6606 Telenzepine dihydrochloride
    中文名: 替仑西平二盐酸盐,太兰泽平二盐酸盐
    Target: M1 Receptors
    Summary: 毒蕈碱M1受体拮抗剂
      Soluble to 100 mM in H2O
  3. GSK269962A
    B3392 GSK269962A
    Target: ROCK|RSK|MSK
    Summary: ROCK抑制剂
      Soluble in DMSO
  4. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  5. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  6. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  7. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  8. Biperiden HCl
    B1598 Biperiden HCl
     1 Citation
    中文名: 盐酸比哌立登
    Target: M1 Receptors
    Summary: 抗胆碱能药物
      ≥8.7 mg/mL
      insoluble in H2O
  9. A-674563
    A8616 A-674563
    Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK
    Summary: Akt1 / PKA / CDK2的强效选择性抑制剂
      ≥4.9 mg/mL
      ≥23.8 mg/mL
  10. LY335979 (Zosuquidar 3HCL)
    A8549 LY335979 (Zosuquidar 3HCL)
     1 Citation
    中文名: 唑喹达三盐酸盐
    Target: P-glycoprotein (P-gp)
    Summary: Pgb(P糖蛋白)抑制剂
      ≥17.1 mg/mL
      ≥31.9 mg/mL

18件产品中的 1-10

页面
每页